Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
The DYNAMIC trial investigated the use of circulating tumor DNA (ctDNA) to guide adjuvant treatment decisions in stage II colon cancer. Despite the DYNAMIC trial ’s assertion that a ctDNA-guided approach could ...
Source: BMC Medicine - Category: Internal Medicine Authors: Timoth ée Olivier, Alyson Haslam and Vinay Prasad Tags: Correspondence Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Internal Medicine